UCB logo

UCB

A biopharmaceutical company focusing on discovery and development of treatments for neurology and immunology conditions

$200.0m

Money raised

Overview

A biopharmaceutical company focusing on discovery and development of treatments for neurology and immunology conditions

Subsidiaries

UCB operates through the following subsidiaries: